Mușat & Asociații team won an important dispute against CNAS for a client in the pharmaceutical industry regarding the application of the legislation on the calculation of the clawback tax

Press release Bucharest, 5 June 2024   Mușat & Asociații represented a multinational pharmaceutical company in a complex dispute with the National Health Insurance House (CNAS) regarding the clawback tax for medicines, in the context of the concurrent application of two special regulations with contradictory provisions, namely GEO No. 31/2020 and Law No. 53/2020. The…

Print Friendly, PDF & Email